Spectrum Pharmaceuticals Inc financial data

Industry
Pharmaceutical Preparations
Location
11500 S. Eastern Ave., Suite 240, Henderson, NV
State of incorporation
Delaware
Fiscal year end
December 31
Former names
NEOTHERAPEUTICS INC (to 12/11/2002)

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 228 % -6.35%
Debt-to-equity 230 % +175%
Return On Equity -210 % -10.1%
Return On Assets -63.5 % +38.7%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 205M shares +15.9%
Common Stock, Shares, Outstanding 205M shares +14.8%
Entity Public Float 115M USD -67.4%
Common Stock, Value, Issued 205K USD +14.5%
Weighted Average Number of Shares Outstanding, Basic 202M shares +19%
Weighted Average Number of Shares Outstanding, Diluted 202M shares +19%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 15.6M USD
Research and Development Expense 43.4M USD -39.8%
Costs and Expenses 89.2M USD -30.3%
Operating Income (Loss) -63.5M USD +50.4%
Nonoperating Income (Expense) -4.17M USD +58.5%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -67.7M USD +51%
Income Tax Expense (Benefit) 30K USD +11.1%
Net Income (Loss) Attributable to Parent -65M USD +53.1%
Earnings Per Share, Basic -0.34 USD/shares +60.5%
Earnings Per Share, Diluted -0.34 USD/shares +60.5%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 52.4M USD -33.4%
Cash, Cash Equivalents, and Short-term Investments 56.1M USD -37.1%
Accounts Receivable, after Allowance for Credit Loss, Current 32.8M USD
Inventory, Net 12.9M USD
Assets, Current 105M USD +13.1%
Property, Plant and Equipment, Net 534K USD +27.8%
Operating Lease, Right-of-Use Asset 1.52M USD -28%
Other Assets, Noncurrent 245K USD -94.4%
Assets 108M USD +7.62%
Contract with Customer, Liability, Current 8.11M USD
Liabilities, Current 38.9M USD -0.83%
Operating Lease, Liability, Noncurrent 858K USD -33.8%
Other Liabilities, Noncurrent 13.1M USD +135%
Liabilities 80.9M USD +80.5%
Accumulated Other Comprehensive Income (Loss), Net of Tax -2.89M USD +0.72%
Retained Earnings (Accumulated Deficit) -1.12B USD -6.13%
Stockholders' Equity Attributable to Parent 26.8M USD -51.5%
Liabilities and Equity 108M USD +7.62%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -21.4M USD +29.2%
Net Cash Provided by (Used in) Financing Activities 2.11M USD -89.4%
Net Cash Provided by (Used in) Investing Activities 31.3M USD +7220%
Common Stock, Shares Authorized 300M shares 0%
Common Stock, Shares, Issued 205M shares +14.8%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 12M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 52.4M USD -33.4%
Interest Paid, Excluding Capitalized Interest, Operating Activities 767K USD
Deferred Tax Assets, Valuation Allowance 256M USD +5.55%
Deferred Tax Assets, Gross 257M USD +5.04%
Operating Lease, Liability 1.63M USD -29.1%
Payments to Acquire Property, Plant, and Equipment 108K USD +177%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -64.9M USD +52.9%
Lessee, Operating Lease, Liability, to be Paid 1.69M USD -29.2%
Operating Lease, Liability, Current 771K USD -23%
Lessee, Operating Lease, Liability, to be Paid, Year Two 188K USD -71.9%
Lessee, Operating Lease, Liability, to be Paid, Year One 820K USD +24.8%
Operating Lease, Weighted Average Discount Rate, Percent 0.03 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 56K USD -32.5%
Lessee, Operating Lease, Liability, to be Paid, Year Three 73K USD -25.5%
Deferred Tax Assets, Operating Loss Carryforwards 198M USD +5.9%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5M shares 0%
Unrecognized Tax Benefits 3.63M USD +2.89%
Lessee, Operating Lease, Liability, to be Paid, Year Four 73K USD -25.5%
Operating Lease, Payments 208K USD -64.4%
Additional Paid in Capital 1.15B USD +3.26%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 45K USD -38.4%
Deferred Tax Assets, Net of Valuation Allowance 522K USD -69.1%
Share-based Payment Arrangement, Expense 7.26M USD -61.1%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%